“It is said that the whole category of diagnostic claims is at risk. It is also said that a crisis of patent law and medical innovation may be upon us, and there seems to be some truth in that concern.”

—Ariosa v. Sequenom 2015 U.S. App. LEXIS 20842 (Fed. Cir. 2015) (en banc)